# Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes

> **NCT00728403** · PHASE2 · UNKNOWN · sponsor: **Unity Health Toronto** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DIETARY_SUPPLEMENT:** American Ginseng (Panax quinquefolius L.) and Korean Red Ginseng (steamed Panax C.A. Meyer)
- **DIETARY_SUPPLEMENT:** American Ginseng (Panax quinquefolius L.)
- **DIETARY_SUPPLEMENT:** Wheat Bran

## Key facts

- **NCT ID:** NCT00728403
- **Lead sponsor:** Unity Health Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2015-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00728403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00728403, "Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00728403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*